Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-09-12
2009-11-10
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S148000
Reexamination Certificate
active
07615564
ABSTRACT:
An objective of the present invention is to provide compounds having Rho kinase inhibitory activity and useful for the treatment of diseases mediated by Rho kinase. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof:wherein Q represents phenyl, pyridyl, pyrrolyl, thienyl, or furyl; these groups are optionally substituted by one or two halogens or alkyl, nitro, or amino groups; and p is 2 or 3.
REFERENCES:
patent: 7217722 (2007-05-01), Takami et al.
patent: 98/06433 (1998-02-01), None
patent: 01/56988 (2001-08-01), None
Iwakubo Masayuki
Okada Yuji
Davis Zinna N
Kirin Beer Kabushiki Kaisha
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Isoquinoline derivatives having kinasae inhibitory activity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline derivatives having kinasae inhibitory activity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives having kinasae inhibitory activity... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4098916